LION
Lionsgate Studios Holding Corp.
11.20$
-1.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +20.3% | +24.8% | +14.0% | +4.3% | +3.4% | -22.0% | +17.2% | +2.0% | +15.6% | +0.2% | +2.5% | |
| – | +1,244.2% | +21.1% | +14.1% | +8.6% | +9.3% | -76.5% | +9.0% | +13.8% | +19.1% | -1.2% | -2.7% | |
| – | -51.7% | -19.2% | +66.0% | +37.0% | +17.3% | +3,276.6% | -28.9% | -17.9% | +31.3% | -25.7% | -11.3% | |
| – | -13.7% | -88.0% | +24.6% | +32.8% | +751.5% | +37.7% | -28.9% | -17.9% | +31.3% | -25.7% | -11.3% | |
| – | – | +28.6% | +14.0% | +8.4% | +2.9% | -87.6% | +51.9% | +26.4% | +11.8% | +5.9% | -25.7% | |
| – | – | – | – | – | – | – | – | +2,749,999,900.0% | -229.5% | – | – | |
| – | – | – | – | – | – | – | +0.0% | +0.0% | +2.0% | -0.3% | +4.7% | |
| – | – | – | – | – | – | – | +26.1% | -4.6% | -98.6% | -19.1% | +29.8% | |
| – | +21.1% | +25.8% | +13.5% | +3.7% | +2.7% | -13.5% | +15.0% | +13.7% | +26.4% | -1.5% | +5.6% | |
| – | +0.0% | +352.1% | +16.0% | -38.1% | -7.2% | +873.3% | +38.7% | +11.7% | +72.7% | -11.9% | -10.6% | |
| – | +0.0% | +352.1% | +16.0% | -38.1% | -7.2% | +179.3% | +126.0% | +9.4% | +133.5% | -18.6% | -25.1% | |
| – | – | – | – | – | – | – | +28.0% | +27.5% | -1.8% | +0.6% | +4.2% | |
| – | – | – | – | – | – | – | – | +17.9% | -33.8% | +24.2% | +33.6% | |
| – | +12.2% | +13.8% | +20.3% | +10.8% | +11.1% | -153.1% | – | – | – | – | – | |
| – | +29.1% | +30.6% | +20.4% | +17.3% | +16.7% | – | – | – | – | – | – | |
| – | +14.4% | +3.9% | +16.6% | +3.5% | +2.0% | -20.2% | -26.4% | +1,689.4% | -11.6% | +12.3% | +1.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.